Cairo - Mubasher: The consolidated financial results of Minapharm Pharmaceuticals showed a 19.45% hike in net profits to EGP 148.41 million during the first quarter (Q1) of 2020, compared to EGP 124.24 million in the same period of 2019.
The company's sales rose to EGP 2.051 million in Q1-2020 from EGP 1.919 million in the year-ago period, according to the company's disclosure to the Egyptian Stock Exchange (EGX) on Monday.
In 2019, the company's net profits declined by 36% year-on-year (YoY) to EGP 46.035 million from EGP 72.12 million in 2018.
Source: Mubasher
All Rights Reserved - Mubasher Info © 2005 - 2020 Provided by SyndiGate Media Inc. (Syndigate.info).
Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.
